Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 129,503 | 99,219 | 81,504 | 65,846 | 71,360 |
| Cost of Goods | 11,688 | 8,685 | 7,492 | 8,830 | 6,905 |
| Gross Profit | 117,815 | 90,534 | 74,012 | 57,016 | 64,455 |
| Operating Expenses | 100,116 | 82,693 | 89,115 | 82,375 | 72,992 |
| Operating Income | 18,387 | 8,526 | -14,611 | -24,529 | -7,632 |
| Interest Expense | 3,001 | 3,071 | 3,029 | 2,982 | 5,551 |
| Other Income | 2,479 | 2,035 | 2,096 | 2,730 | 2,718 |
| Pre-tax Income | 17,865 | 7,490 | -15,544 | -24,781 | -10,465 |
| Income Tax | 470 | 80 | 342 | 279 | 323 |
| Net Income Continuous | 17,395 | 7,410 | -15,886 | -25,060 | -10,788 |
| Net Income | $17,395 | $7,410 | $-15,886 | $-25,060 | $-10,788 |
| EPS Basic Total Ops | 0.14 | 0.06 | -0.13 | -0.20 | -0.09 |
| EPS Basic Continuous Ops | 0.14 | 0.06 | -0.13 | -0.20 | -0.08 |
| EPS Diluted Total Ops | 0.14 | 0.06 | -0.13 | -0.20 | -0.09 |
| EPS Diluted Continuous Ops | 0.14 | 0.06 | -0.13 | -0.20 | -0.08 |
| EPS Diluted Before Non-Recurring Items | 0.13 | 0.06 | -0.13 | -0.20 | -0.09 |
| EBITDA(a) | $18,961 | $8,537 | $-14,896 | $-22,256 | $-8,415 |